Clinical Trial Update: Gynecomastia Extension Study [Phase 3]

View source ↗

Summary

A Phase 3 extension study evaluating tamoxifen for gynecomastia has completed, with results from the extended trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecomastia

Drugs mentioned

• Nolvadex (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Gynecomastia | Phase 3 | Status: COMPLETED